QNCX

QNCX

USD

Quince Therapeutics Inc. Common Stock

$1.600+0.040 (2.564%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$1.560

Haut

$1.620

Bas

$1.555

Volume

0.11M

Fondamentaux de l'Entreprise

Capitalisation Boursière

85.9M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.27M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $0.72Actuel $1.600Haut $2.45

Actualités Connexes

BusinessWire

Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting

Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced the poster presentation of

Voir plus
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
Analyst Upgrades

D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target

D. Boral Capital analyst Jason Kolbert maintains Quince Therapeutics with a Buy and maintains $4 price target.

Voir plus
D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target
BusinessWire

Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study

Quince Therapeutics, Inc.

Voir plus
Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study